A hitchhiker's guide through the COVID-19 galaxy.

Susanna Felsenstein, Andreas Otto Reiff
Author Information
  1. Susanna Felsenstein: University of Liverpool, Faculty of Health and Life Sciences, Brownlow Hill, Liverpool, L69 3GB, United Kingdom. Electronic address: sumakafe@liverpool.ac.uk.
  2. Andreas Otto Reiff: Arthritis & Rheumatic Diseases, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, United States. Electronic address: reiffa@ohsu.edu.

Abstract

Numerous reviews have summarized the epidemiology, pathophysiology and the various therapeutic aspects of Coronavirus disease 2019 (COVID-19), but a practical guide on "how to treat whom with what and when" based on an understanding of the immunological background of the disease stages remains missing. This review attempts to combine the current knowledge about the immunopathology of COVID-19 with published evidence of available and emerging treatment options. We recognize that the information about COVID-19 and its treatment is rapidly changing, but hope that this guide offers those on the frontline of this pandemic an understanding of the host response in COVID-19 patients and supports their ongoing efforts to select the best treatments tailored to their patient's clinical status.

References

  1. Angiogenesis. 2021 Aug;24(3):505-517 [PMID: 33449299]
  2. JAMA. 2020 Apr 7;323(13):1239-1242 [PMID: 32091533]
  3. Am J Gastroenterol. 2010 Oct;105(10):2287-92 [PMID: 20461065]
  4. Int J Radiat Biol. 2020 Nov;96(11):1323-1328 [PMID: 32910699]
  5. J Med Virol. 2021 Mar;93(3):1265-1275 [PMID: 32808712]
  6. Ann Rheum Dis. 2021 Jan;80(1):88-95 [PMID: 32978237]
  7. Nat Commun. 2021 Mar 30;12(1):1967 [PMID: 33785743]
  8. N Engl J Med. 2021 Feb 25;384(8):693-704 [PMID: 32678530]
  9. J Infect Dis. 2021 Mar 29;223(6):933-944 [PMID: 33280009]
  10. N Engl J Med. 2021 Feb 11;384(6):497-511 [PMID: 33264556]
  11. J Interferon Cytokine Res. 2020 Sep;40(9):438-442 [PMID: 32960147]
  12. J Clin Invest. 2019 Jul 29;129(9):3625-3639 [PMID: 31355779]
  13. Am J Respir Crit Care Med. 2011 Feb 15;183(4):462-70 [PMID: 20802164]
  14. JAMA. 2020 Aug 25;324(8):782-793 [PMID: 32648899]
  15. JAMA. 2020 Sep 15;324(11):1048-1057 [PMID: 32821939]
  16. Clin Infect Dis. 2021 Nov 2;73(9):e2995-e3001 [PMID: 32856036]
  17. Life Sci Alliance. 2020 Dec 24;4(2): [PMID: 33361110]
  18. J Infect. 2021 Aug;83(2):e15-e17 [PMID: 34146596]
  19. Eur J Clin Invest. 2018 Nov;48 Suppl 2:e12967 [PMID: 29896919]
  20. Nat Med. 2021 Oct;27(10):1674-1675 [PMID: 34480126]
  21. Am J Physiol Lung Cell Mol Physiol. 2015 Jun 15;308(12):L1212-23 [PMID: 25888574]
  22. Circ Res. 2011 Apr 29;108(9):1102-11 [PMID: 21415394]
  23. Chest. 2021 Feb;159(2):524-536 [PMID: 33069725]
  24. N Engl J Med. 2020 Mar 26;382(13):1199-1207 [PMID: 31995857]
  25. Lancet. 2020 May 30;395(10238):1695-1704 [PMID: 32401715]
  26. Int J Infect Dis. 2020 Nov;100:34-41 [PMID: 32798659]
  27. Am J Respir Crit Care Med. 2001 May;163(6):1376-83 [PMID: 11371404]
  28. Exp Cell Res. 2019 Sep 15;382(2):111486 [PMID: 31255598]
  29. Heart. 2020 Oct;106(19):1512-1518 [PMID: 32817312]
  30. Am J Respir Crit Care Med. 2002 Nov 15;166(10):1332-7 [PMID: 12421742]
  31. Am J Physiol Lung Cell Mol Physiol. 2004 Jan;286(1):L156-64 [PMID: 12754187]
  32. Crit Care Med. 2013 Jan;41(1):224-36 [PMID: 23222256]
  33. Lancet Respir Med. 2021 Mar;9(3):295-304 [PMID: 33493450]
  34. Crit Care Med. 2012 Jun;40(6):1731-7 [PMID: 22610178]
  35. Immunology. 1988 Jun;64(2):301-5 [PMID: 3134297]
  36. Nat Commun. 2021 Jan 11;12(1):267 [PMID: 33431879]
  37. Eur Rev Med Pharmacol Sci. 2015;19(14):2621-7 [PMID: 26221892]
  38. J Appl Physiol (1985). 2004 Nov;97(5):1605-17 [PMID: 15475552]
  39. Cell Host Microbe. 2016 Feb 10;19(2):181-93 [PMID: 26867177]
  40. J Clin Invest. 2020 Dec 1;130(12):6409-6416 [PMID: 32809969]
  41. Am J Cardiol. 2020 Nov 1;134:153-155 [PMID: 32891399]
  42. Trials. 2020 Jul 08;21(1):626 [PMID: 32641154]
  43. Intern Emerg Med. 2020 Aug;15(5):861-863 [PMID: 32557383]
  44. Blood. 2020 Sep 3;136(10):1169-1179 [PMID: 32597954]
  45. Mol Cell Pediatr. 2016 Dec;3(1):29 [PMID: 27480877]
  46. N Engl J Med. 2021 Aug 26;385(9):826-832 [PMID: 34437785]
  47. J Leukoc Biol. 2010 Jul;88(1):211-20 [PMID: 20400675]
  48. Lancet Respir Med. 2021 Apr;9(4):397-406 [PMID: 33600777]
  49. Front Immunol. 2019 Jun 25;10:1426 [PMID: 31293586]
  50. J Hosp Med. 2021 Feb;16(2):90-92 [PMID: 33147129]
  51. Lancet Infect Dis. 2021 Jun;21(6):e149-e162 [PMID: 33333012]
  52. Am J Physiol Lung Cell Mol Physiol. 2013 Nov 15;305(10):L665-81 [PMID: 24039257]
  53. Haematologica. 2020 Jul 23;105(12):2847-2850 [PMID: 33256385]
  54. Crit Care Med. 2012 Jan;40(1):90-7 [PMID: 21926600]
  55. Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):4040-4047 [PMID: 32329881]
  56. J Virol. 2007 Aug;81(16):8722-9 [PMID: 17522231]
  57. N Engl J Med. 2021 Aug 26;385(9):790-802 [PMID: 34351721]
  58. Am J Ther. 2021 Jun 21;28(4):e434-e460 [PMID: 34145166]
  59. N Engl J Med. 2020 Feb 20;382(8):727-733 [PMID: 31978945]
  60. J Immunol. 2019 Aug 15;203(4):1021-1030 [PMID: 31263039]
  61. JAMA. 2020 Mar 17;323(11):1061-1069 [PMID: 32031570]
  62. New Microbes New Infect. 2020 Sep;37:100756 [PMID: 32922804]
  63. Nat Immunol. 2008 Sep;9(9):1074-83 [PMID: 18660812]
  64. Am J Respir Crit Care Med. 2013 Apr 1;187(7):736-42 [PMID: 23328529]
  65. Thorax. 2021 Sep;76(9):907-919 [PMID: 33579777]
  66. Reumatol Clin (Engl Ed). 2020 Nov 28;: [PMID: 33358361]
  67. J Infect. 2020 Aug;81(2):e16-e25 [PMID: 32335169]
  68. Cochrane Database Syst Rev. 2018 Sep 06;9:CD001127 [PMID: 30187450]
  69. Expert Rev Cardiovasc Ther. 2020 Dec;18(12):919-930 [PMID: 32945216]
  70. Cell. 2020 Oct 1;183(1):16-27.e1 [PMID: 32882182]
  71. JAMA Cardiol. 2020 Jul 1;5(7):811-818 [PMID: 32219356]
  72. J Transl Med. 2017 Aug 29;15(1):181 [PMID: 28851381]
  73. Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759 [PMID: 32663409]
  74. Eur J Clin Invest. 2020 Sep;50(9):e13314 [PMID: 32535885]
  75. Nat Med. 2020 Jun;26(6):842-844 [PMID: 32398875]
  76. N Engl J Med. 2020 Apr 30;382(18):1708-1720 [PMID: 32109013]
  77. Lancet Respir Med. 2021 Jul;9(7):763-772 [PMID: 33844996]
  78. Ann Intern Med. 2020 Oct 20;173(8):623-631 [PMID: 32673060]
  79. J Mol Cell Cardiol. 2020 Oct;147:74-87 [PMID: 32827510]
  80. Nat Commun. 2021 Feb 5;12(1):814 [PMID: 33547300]
  81. JAMA Intern Med. 2020 Aug 1;180(8):1081-1089 [PMID: 32396163]
  82. J Clin Invest. 2020 Dec 1;130(12):6290-6300 [PMID: 32784290]
  83. Lancet. 2020 May 2;395(10234):1417-1418 [PMID: 32325026]
  84. Lancet. 2021 May 01;397(10285):1637-1645 [PMID: 33933206]
  85. Shock. 2017 Jan;47(1):13-21 [PMID: 27984533]
  86. Leukemia. 2021 Sep;35(9):2710-2714 [PMID: 34031531]
  87. Lancet Respir Med. 2021 Sep;9(9):957-968 [PMID: 34147142]
  88. Science. 2017 Dec 1;358(6367):1202-1206 [PMID: 29191910]
  89. Methods Mol Biol. 2020;2099:195-204 [PMID: 31883097]
  90. Mol Med. 2001 Apr;7(4):240-6 [PMID: 11471568]
  91. Lancet. 2020 Mar 28;395(10229):1054-1062 [PMID: 32171076]
  92. Am J Respir Crit Care Med. 2021 Jan 1;203(1):54-66 [PMID: 33119402]
  93. J Infect Chemother. 2020 Dec;26(12):1319-1323 [PMID: 32893123]
  94. J Cell Mol Med. 2021 Jan;25(2):1263-1273 [PMID: 33336936]
  95. N Engl J Med. 2020 Jul 9;383(2):120-128 [PMID: 32437596]
  96. Nat Rev Immunol. 2013 Mar;13(3):159-75 [PMID: 23435331]
  97. PLoS One. 2012;7(2):e32366 [PMID: 22389696]
  98. Lancet Respir Med. 2018 Sep;6(9):691-698 [PMID: 30078618]
  99. Virulence. 2013 Aug 15;4(6):517-24 [PMID: 23652985]
  100. Cell. 2020 Apr 16;181(2):281-292.e6 [PMID: 32155444]
  101. J Allergy Clin Immunol. 2020 Jul;146(1):137-146.e3 [PMID: 32470486]
  102. Int J Public Health. 2020 Jun;65(5):533-546 [PMID: 32451563]
  103. Front Immunol. 2016 Sep 19;7:366 [PMID: 27698656]
  104. Int J Infect Dis. 2021 Feb;103:288-296 [PMID: 33217576]
  105. Euroasian J Hepatogastroenterol. 2020 Jul-Dec;10(2):68-75 [PMID: 33511068]
  106. J Biol Chem. 2010 Jul 30;285(31):23842-9 [PMID: 20519501]
  107. Eur J Clin Pharmacol. 2020 Dec;76(12):1623-1630 [PMID: 32696234]
  108. Mod Pathol. 2020 Nov;33(11):2156-2168 [PMID: 32879413]
  109. N Engl J Med. 2020 Aug 6;383(6):517-525 [PMID: 32492293]
  110. Int Immunopharmacol. 2020 Aug;85:106683 [PMID: 32531713]
  111. Trends Pharmacol Sci. 2008 Jul;29(7):367-74 [PMID: 18579222]
  112. PLoS Med. 2006 Mar;3(3):e46 [PMID: 16417407]
  113. J Allergy Clin Immunol. 2021 Feb;147(2):510-519.e5 [PMID: 33068560]
  114. Clin Infect Dis. 2020 Nov 19;71(16):2199-2206 [PMID: 32407459]
  115. Cells. 2020 Jun 02;9(6): [PMID: 32498376]
  116. Curr Top Med Chem. 2021;21(10):920-927 [PMID: 33970846]
  117. Med Sci Monit. 2005 Jun;11(6):RA194-205 [PMID: 15917731]
  118. Dig Dis Sci. 2020 Jul;65(7):1932-1939 [PMID: 32447742]
  119. Lancet Infect Dis. 2014 Jan;14(1):57-69 [PMID: 24239327]
  120. J Thromb Thrombolysis. 2020 Nov;50(4):814-821 [PMID: 32748122]
  121. Viruses. 2020 Jun 10;12(6): [PMID: 32532094]
  122. Nat Rev Immunol. 2020 Sep;20(9):515-516 [PMID: 32728221]
  123. J Thromb Haemost. 2020 Nov;18(11):2942-2953 [PMID: 32881304]
  124. Nat Med. 2006 Feb;12(2):235-9 [PMID: 16462802]
  125. Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):602-11 [PMID: 8810593]
  126. Lancet Infect Dis. 2020 Jun;20(6):656-657 [PMID: 32199493]
  127. N Engl J Med. 2021 Mar 18;384(11):1015-1027 [PMID: 33523609]
  128. J Allergy Clin Immunol. 2021 Feb;147(2):561-566.e4 [PMID: 33220354]
  129. Travel Med Infect Dis. 2020 Mar - Apr;34:101623 [PMID: 32179124]
  130. Intern Emerg Med. 2021 Jun;16(4):843-852 [PMID: 33400157]
  131. Nat Commun. 2017 Oct 27;8(1):1173 [PMID: 29079808]
  132. Am J Respir Crit Care Med. 2020 Dec 1;202(11):1509-1519 [PMID: 32866033]
  133. Cell. 2020 Jul 23;182(2):429-446.e14 [PMID: 32526206]
  134. Proc Natl Acad Sci U S A. 2021 Aug 24;118(34): [PMID: 34376550]
  135. Sci Immunol. 2021 Apr 7;6(58): [PMID: 33827897]
  136. Br J Anaesth. 2018 Nov;121(5):1041-1051 [PMID: 30336848]
  137. N Engl J Med. 2020 Sep 10;383(11):1087-1088 [PMID: 32668106]
  138. J Infect. 2020 Oct;81(4):647-679 [PMID: 32592703]
  139. Intensive Care Med. 2020 Apr;46(4):586-590 [PMID: 32125455]
  140. Lancet Respir Med. 2021 Dec;9(12):1407-1418 [PMID: 34480861]
  141. Exp Cell Res. 2020 Sep 15;394(2):112101 [PMID: 32474064]
  142. Cancer Metastasis Rev. 2000;19(1-2):13-7 [PMID: 11191051]
  143. Pharmaceuticals (Basel). 2021 Jun 28;14(7): [PMID: 34203121]
  144. Crit Care. 2017 Sep 7;21(1):234 [PMID: 28877748]
  145. Thorax. 2008 Oct;63(10):903-9 [PMID: 18559364]
  146. Annu Rev Physiol. 2017 Feb 10;79:541-566 [PMID: 27813830]
  147. Nat Immunol. 2013 Aug;14(8):821-30 [PMID: 23812096]
  148. Shock. 2019 Mar;51(3):298-305 [PMID: 30286031]
  149. Nature. 2020 May;581(7809):465-469 [PMID: 32235945]
  150. J Hepatol. 2020 Nov;73(5):1231-1240 [PMID: 32553666]
  151. JAMA. 2020 Oct 6;324(13):1330-1341 [PMID: 32876694]
  152. Crit Care. 2020 Jun 18;24(1):356 [PMID: 32552872]
  153. PLoS One. 2020 Jun 23;15(6):e0234765 [PMID: 32574165]
  154. Circulation. 2020 Nov 10;142(19):1881-1884 [PMID: 32970476]
  155. J Med Virol. 2020 Nov;92(11):2573-2581 [PMID: 32458459]
  156. Eur J Clin Invest. 2020 Oct;50(10):e13362 [PMID: 32726868]
  157. Sci Adv. 2020 Nov 20;6(47): [PMID: 33097472]
  158. Clin Infect Dis. 2021 Nov 2;73(9):e2952-e2959 [PMID: 33098412]
  159. Transfus Apher Sci. 2020 Oct;59(5):102875 [PMID: 32694043]
  160. J Thromb Haemost. 2020 Jun;18(6):1521-1522 [PMID: 32302456]
  161. J Immunol. 2011 Jul 1;187(1):538-52 [PMID: 21613614]
  162. Cochrane Database Syst Rev. 2021 May 20;5:CD013600 [PMID: 34013969]
  163. F1000Res. 2019 Nov 22;8: [PMID: 31824644]
  164. Trials. 2020 Nov 19;21(1):935 [PMID: 33213530]
  165. Am J Physiol Lung Cell Mol Physiol. 2015 Dec 1;309(11):L1294-304 [PMID: 26432864]
  166. Endocr Metab Immune Disord Drug Targets. 2020;20(6):807-811 [PMID: 32338224]
  167. J Transl Med. 2020 May 20;18(1):206 [PMID: 32434518]
  168. Acute Med Surg. 2020 Dec 06;7(1):e585 [PMID: 33042560]
  169. J Virol. 2020 Mar 17;94(7): [PMID: 31996437]
  170. Crit Care. 2020 Jun 12;24(1):335 [PMID: 32532353]
  171. Crit Care. 2020 Aug 21;24(1):516 [PMID: 32825837]
  172. Lancet. 2017 Sep 23;390(10101):1511-1520 [PMID: 28754494]
  173. Biosci Rep. 2020 Jun 26;40(6): [PMID: 32441299]
  174. Sci Rep. 2021 Jan 26;11(1):2256 [PMID: 33500431]
  175. Science. 2004 Mar 5;303(5663):1532-5 [PMID: 15001782]
  176. N Engl J Med. 2021 Jul 29;385(5):406-415 [PMID: 34133856]
  177. Lancet Rheumatol. 2020 Dec;2(12):e764-e773 [PMID: 33015643]
  178. Ann Intern Med. 2020 Aug 18;173(4):268-277 [PMID: 32374815]
  179. Lancet Rheumatol. 2021 Jun;3(6):e410-e418 [PMID: 33754144]
  180. Crit Care Med. 2000 Jan;28(1):1-7 [PMID: 10667491]
  181. Crit Care. 2019 Apr 11;23(1):117 [PMID: 30975180]
  182. J Pathol. 2004 Jun;203(2):631-7 [PMID: 15141377]
  183. Kidney Int. 2000 Jun;57(6):2285-98 [PMID: 10844599]
  184. Kidney Int. 2008 Sep;74(5):585-95 [PMID: 18509316]
  185. J Surg Res. 2006 Mar;131(1):105-10 [PMID: 16256138]
  186. Cochrane Database Syst Rev. 2020 Jul 7;7:CD013665 [PMID: 32633856]
  187. N Engl J Med. 2021 Mar 4;384(9):795-807 [PMID: 33306283]
  188. Intensive Care Med. 2020 Jun;46(6):1089-1098 [PMID: 32367170]
  189. Nat Rev Immunol. 2011 Oct 14;11(11):723-37 [PMID: 21997792]
  190. Immunity. 2021 Mar 9;54(3):557-570.e5 [PMID: 33577760]
  191. Annu Rev Immunol. 2005;23:821-52 [PMID: 15771587]
  192. Nat Commun. 2015 Jan 30;6:5962 [PMID: 25635707]
  193. N Engl J Med. 2019 Dec 12;381(24):2293-2303 [PMID: 31774950]
  194. Nature. 2020 Aug;584(7821):430-436 [PMID: 32640463]
  195. Nature. 2021 Apr;592(7855):616-622 [PMID: 33567448]
  196. Nat Rev Immunol. 2014 Feb;14(2):81-93 [PMID: 24445666]
  197. Int Immunopharmacol. 2020 Nov;88:106903 [PMID: 32862111]
  198. Lancet Respir Med. 2021 May;9(5):498-510 [PMID: 33556319]
  199. Clin Transl Sci. 2020 Sep;13(5):896-906 [PMID: 32589775]
  200. Nat Rev Immunol. 2020 Jun;20(6):355-362 [PMID: 32376901]
  201. Cell Mol Immunol. 2019 Jan;16(1):19-27 [PMID: 29572545]
  202. EClinicalMedicine. 2021 May;35:100849 [PMID: 33903855]
  203. Elife. 2021 Mar 08;10: [PMID: 33682678]
  204. J Cell Physiol. 2018 Sep;233(9):6425-6440 [PMID: 29319160]
  205. Lancet Infect Dis. 2020 Apr;20(4):400-402 [PMID: 32113509]
  206. N Engl J Med. 2021 Aug 26;385(9):777-789 [PMID: 34351722]
  207. Crit Care Res Pract. 2021 Apr 23;2021:8881115 [PMID: 33986957]
  208. Trials. 2020 Jun 19;21(1):548 [PMID: 32560746]
  209. Thorax. 2014 Jul;69(7):623-9 [PMID: 24706039]
  210. BMJ. 2021 Jun 15;373:n1412 [PMID: 34130987]
  211. J Med Virol. 2021 May;93(5):3165-3175 [PMID: 33590923]
  212. Int J Lab Hematol. 2020 Dec;42(6):e244-e247 [PMID: 32779881]
  213. N Engl J Med. 2020 Dec 10;383(24):2333-2344 [PMID: 33085857]
  214. Nat Immunol. 2015 Jan;16(1):27-35 [PMID: 25521682]
  215. Front Pharmacol. 2020 Jun 05;11:857 [PMID: 32581810]
  216. Nat Med. 2006 Nov;12(11):1286-93 [PMID: 17086189]
  217. J Inflamm (Lond). 2013 Feb 11;10(1):6 [PMID: 23394254]
  218. Lancet Respir Med. 2020 Jul;8(7):681-686 [PMID: 32473124]
  219. Life Sci. 2020 Jul 15;253:117592 [PMID: 32222463]
  220. Crit Care. 2008;12(6):R147 [PMID: 19025590]
  221. Lancet Rheumatol. 2020 Jul;2(7):e393-e400 [PMID: 32835245]
  222. Nature. 2021 Mar;591(7850):451-457 [PMID: 33561864]
  223. Expert Rev Vaccines. 2021 Apr;20(4):365-373 [PMID: 33851875]
  224. N Engl J Med. 2021 Jan 21;384(3):238-251 [PMID: 33332778]
  225. Cell Host Microbe. 2020 Sep 9;28(3):455-464.e2 [PMID: 32707096]
  226. Lancet Infect Dis. 2020 Aug;20(8):e192-e197 [PMID: 32539990]
  227. Nat Commun. 2020 Oct 2;11(1):4968 [PMID: 33009413]
  228. Nat Cell Biol. 2008 May;10(5):527-37 [PMID: 18425119]
  229. Nature. 2021 Jul;595(7866):278-282 [PMID: 34098567]
  230. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):260-268 [PMID: 32712702]
  231. Sci Immunol. 2019 May 17;4(35): [PMID: 31101672]
  232. Arterioscler Thromb Vasc Biol. 2015 May;35(5):1071-9 [PMID: 25814671]
  233. JAMA. 2012 Jun 20;307(23):2526-33 [PMID: 22797452]
  234. J Immunol. 2001 Apr 1;166(7):4644-9 [PMID: 11254723]
  235. J Thromb Haemost. 2020 Aug;18(8):1995-2002 [PMID: 32369666]
  236. Eur Respir J. 2005 Jan;25(1):139-46 [PMID: 15640335]
  237. Inflamm Res. 2020 Sep;69(9):883-895 [PMID: 32647933]
  238. Nat Med. 2021 Nov;27(11):2012-2024 [PMID: 34504336]
  239. Anesth Analg. 2021 Apr 1;132(4):930-941 [PMID: 33093359]
  240. Pharmaceutics. 2020 Oct 22;12(11): [PMID: 33105618]
  241. Emerg Med J. 2021 Jul;38(7):543-548 [PMID: 34021028]
  242. Infection. 2020 Aug;48(4):577-584 [PMID: 32440918]
  243. Clin Microbiol Infect. 2021 Jan;27(1):19-27 [PMID: 32860962]
  244. Clin Infect Dis. 2022 Mar 23;74(6):1022-1029 [PMID: 34181716]
  245. EClinicalMedicine. 2021 May;35:100859 [PMID: 33937732]
  246. Sci Rep. 2015 Jun 05;5:11030 [PMID: 26046800]
  247. Life Sci. 2020 Sep 15;257:118102 [PMID: 32687918]
  248. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600 [PMID: 33044747]
  249. BMJ. 2020 Oct 20;371:m3731 [PMID: 33082154]
  250. Angiogenesis. 2021 Feb;24(1):145-157 [PMID: 33058027]
  251. Clin Infect Dis. 2021 Aug 2;73(3):531-534 [PMID: 32770240]
  252. Crit Care. 2020 Apr 30;24(1):187 [PMID: 32354367]
  253. J Allergy Clin Immunol. 2021 Apr;147(4):1217-1225 [PMID: 33556464]
  254. Nat Commun. 2021 May 4;12(1):2506 [PMID: 33947851]
  255. FEBS Lett. 2010 Jul 16;584(14):3193-7 [PMID: 20541553]
  256. Acta Biomed. 2020 Sep 07;91(3):e2020008 [PMID: 32921706]
  257. Nature. 2017 Mar 9;543(7644):248-251 [PMID: 28151488]
  258. Lancet. 2020 Feb 15;395(10223):497-506 [PMID: 31986264]
  259. Expert Rev Vaccines. 2021 Oct;20(10):1201-1209 [PMID: 34488546]
  260. PLoS One. 2021 Jun 25;16(6):e0253767 [PMID: 34170950]
  261. J Emerg Med. 2021 Sep;61(3):298-313 [PMID: 34092446]
  262. J Pathol. 2002 Oct;198(2):270-5 [PMID: 12237888]
  263. Circulation. 2005 Jan 4;111(1):97-105 [PMID: 15611372]
  264. EClinicalMedicine. 2020 Nov;28:100590 [PMID: 33173853]
  265. Angiogenesis. 2020 Nov;23(4):611-620 [PMID: 32458111]
  266. J Infect Dis. 2021 Jan 4;223(1):38-46 [PMID: 33098643]
  267. Nature. 2020 Dec;588(7836):146-150 [PMID: 32726800]
  268. Eur Respir J. 2011 Mar;37(3):604-9 [PMID: 20562130]
  269. MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415 [PMID: 32271722]
  270. Elife. 2020 Oct 12;9: [PMID: 33044170]
  271. Intern Emerg Med. 2020 Nov;15(8):1485-1499 [PMID: 32970246]
  272. Nat Med. 2020 May;26(5):672-675 [PMID: 32296168]
  273. Thromb Res. 2020 Jul;191:145-147 [PMID: 32291094]
  274. PLoS One. 2013 Aug 05;8(8):e70459 [PMID: 23940579]
  275. Nat Rev Immunol. 2020 Oct;20(10):585-586 [PMID: 32788708]
  276. J Exp Med. 2020 Jan 6;217(1): [PMID: 31611249]
  277. Sci Rep. 2021 Mar 2;11(1):4945 [PMID: 33654180]
  278. Lancet Infect Dis. 2020 May;20(5):565-574 [PMID: 32213337]
  279. Front Microbiol. 2017 Jun 16;8:1117 [PMID: 28670306]
  280. BMC Infect Dis. 2021 Jan 11;21(1):47 [PMID: 33430799]
  281. Fundam Clin Pharmacol. 2021 Apr;35(2):260-276 [PMID: 33427370]
  282. JAMA Intern Med. 2021 Jan 1;181(1):32-40 [PMID: 33080017]
  283. Transl Res. 2020 Jun;220:1-13 [PMID: 32299776]
  284. Ann Intern Med. 2020 May 05;172(9):577-582 [PMID: 32150748]
  285. J Thromb Haemost. 2020 Aug;18(8):1859-1865 [PMID: 32459046]
  286. Lancet. 2020 Jun 27;395(10242):1973-1987 [PMID: 32497510]
  287. Lancet. 2020 Oct 3;396(10256):959-967 [PMID: 32896292]
  288. MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176 [PMID: 34437525]
  289. Cell. 2020 Sep 17;182(6):1419-1440.e23 [PMID: 32810438]
  290. J Infect. 2020 Aug;81(2):318-356 [PMID: 32333918]
  291. J Cardiothorac Vasc Anesth. 2021 Feb;35(2):578-584 [PMID: 33298370]
  292. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1460-1466 [PMID: 33123760]
  293. BMJ. 2020 Oct 22;371:m3939 [PMID: 33093056]
  294. Physiol Rev. 2018 Jul 1;98(3):1627-1738 [PMID: 29873596]
  295. Eur Respir J. 2020 May 14;55(5): [PMID: 32217650]
  296. N Engl J Med. 2021 Sep 23;385(13):1184-1195 [PMID: 34347950]
  297. Clin Cancer Res. 2018 Apr 1;24(7):1536-1545 [PMID: 29217526]
  298. J Thromb Haemost. 2020 May;18(5):1094-1099 [PMID: 32220112]
  299. J Infect Dis. 2020 Oct 13;222(10):1620-1628 [PMID: 32779705]
  300. Respiration. 2014;87(4):329-42 [PMID: 24356493]
  301. Shock. 2008 Jun;29(6):656-61 [PMID: 18091573]
  302. JAMA. 2020 Aug 4;324(5):460-470 [PMID: 32492084]
  303. Crit Care. 2020 Jul 17;24(1):444 [PMID: 32680535]
  304. Am J Physiol Lung Cell Mol Physiol. 2011 Jun;300(6):L851-62 [PMID: 21421750]
  305. Am Rev Respir Dis. 1989 Dec;140(6):1686-92 [PMID: 2604296]
  306. J Clin Invest. 2012 Jan;122(1):327-36 [PMID: 22156198]
  307. Trials. 2020 Jun 05;21(1):491 [PMID: 32503663]
  308. J Med Virol. 2020 Oct;92(10):1721-1723 [PMID: 32232976]
  309. Am J Physiol Lung Cell Mol Physiol. 2000 Jul;279(1):L25-35 [PMID: 10893199]
  310. Clin Infect Dis. 2020 Sep 12;71(6):1400-1409 [PMID: 32270184]
  311. J Thromb Thrombolysis. 2020 Aug;50(2):287-291 [PMID: 32445064]
  312. Nat Commun. 2021 Apr 15;12(1):2349 [PMID: 33859192]
  313. Science. 1999 Dec 24;286(5449):2511-4 [PMID: 10617467]
  314. Crit Care. 2020 Aug 12;24(1):497 [PMID: 32787901]
  315. PLoS One. 2021 Jan 29;16(1):e0246182 [PMID: 33513168]
  316. Annu Rev Immunol. 1998;16:293-322 [PMID: 9597132]
  317. J Intensive Care Med. 2015 May;30(4):209-16 [PMID: 24362445]
  318. N Engl J Med. 2021 Feb 18;384(7):619-629 [PMID: 33232588]
  319. EBioMedicine. 2020 Aug;58:102925 [PMID: 32745993]
  320. Clin Immunol. 2020 Nov;220:108598 [PMID: 32961333]
  321. Am J Ther. 2020 Nov/Dec;27(6):e599-e610 [PMID: 33156016]
  322. Clin Infect Dis. 2021 Dec 6;73(11):e3884-e3899 [PMID: 33270107]
  323. Front Immunol. 2019 Mar 14;10:449 [PMID: 30923524]
  324. Eur J Clin Invest. 2021 Jan;51(1):e13433 [PMID: 33053206]
  325. N Engl J Med. 2020 Apr 23;382(17):e38 [PMID: 32268022]
  326. N Engl J Med. 2020 Nov 5;383(19):1813-1826 [PMID: 32445440]
  327. Nat Immunol. 2020 Nov;21(11):1336-1345 [PMID: 32887977]
  328. Pharmacol Res. 2020 Nov;161:105250 [PMID: 33059010]
  329. Nat Commun. 2021 May 27;12(1):3189 [PMID: 34045486]
  330. Int J Infect Dis. 2021 Jun;107:232-233 [PMID: 33965598]
  331. N Engl J Med. 2020 Nov 19;383(21):2041-2052 [PMID: 32706953]
  332. Am J Respir Crit Care Med. 2001 Nov 1;164(9):1601-5 [PMID: 11719296]
  333. Vaccine. 2021 Jul 22;39(32):4423-4428 [PMID: 34210573]
  334. Antimicrob Agents Chemother. 2020 May 21;64(6): [PMID: 32312781]
  335. Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3 [PMID: 32320677]
  336. Nat Rev Nephrol. 2018 May;14(5):325-336 [PMID: 29578208]
  337. Clin Med (Lond). 2020 Sep;20(5):e178-e182 [PMID: 32694169]
  338. J Exp Pharmacol. 2021 Apr 16;13:461-468 [PMID: 33889032]
  339. J Exp Med. 1983 Sep 1;158(3):670-89 [PMID: 6411853]
  340. Lancet Rheumatol. 2020 Aug;2(8):e465-e473 [PMID: 32835256]
  341. Clin Immunol. 2020 Aug;217:108509 [PMID: 32535188]
  342. Front Immunol. 2021 Apr 29;12:675678 [PMID: 33995419]
  343. Thromb Res. 2020 Dec;196:313-317 [PMID: 32977129]
  344. Cell. 2020 May 14;181(4):905-913.e7 [PMID: 32333836]
  345. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346 [PMID: 32214079]
  346. Cell. 2020 Jul 9;182(1):59-72.e15 [PMID: 32492406]
  347. Eur J Intern Med. 2020 Jun;76:14-20 [PMID: 32336612]
  348. Radiology. 2021 Feb;298(2):E70-E80 [PMID: 33320063]
  349. Semin Thromb Hemost. 2020 Oct;46(7):763-771 [PMID: 32882719]
  350. Circulation. 2020 Jul 14;142(2):184-186 [PMID: 32330083]
  351. JAMA. 2016 Jun 14;315(22):2406-14 [PMID: 27179988]
  352. J Allergy Clin Immunol. 2021 Jan;147(1):72-80.e8 [PMID: 33010257]
  353. Nat Med. 2020 Oct;26(10):1636-1643 [PMID: 32839624]
  354. New Microbes New Infect. 2020 Apr 30;35:100689 [PMID: 32355564]
  355. N Engl J Med. 2021 Apr 22;384(16):1503-1516 [PMID: 33631066]
  356. Science. 2020 Aug 7;369(6504):718-724 [PMID: 32661059]
  357. Nat Rev Mol Cell Biol. 2020 Jul;21(7):398-414 [PMID: 32251387]
  358. Matrix Biol. 2001 Sep;20(5-6):319-25 [PMID: 11566266]
  359. N Engl J Med. 2020 May 14;382(20):e60 [PMID: 32343504]
  360. Int J Lab Hematol. 2021 Apr;43(2):324-328 [PMID: 33010111]
  361. Lancet Respir Med. 2021 Feb;9(2):196-206 [PMID: 33189161]
  362. N Engl J Med. 2021 Jan 7;384(1):20-30 [PMID: 33332779]
  363. Tissue Barriers. 2015 Apr 03;3(1-2):e957508 [PMID: 25838975]
  364. Eur Respir J. 2012 Jul;40(1):206-14 [PMID: 22267753]
  365. Pulm Ther. 2021 Dec;7(2):487-501 [PMID: 34189703]
  366. J Biol Chem. 2020 May 15;295(20):6785-6797 [PMID: 32284326]
  367. BMJ. 2020 May 22;369:m1985 [PMID: 32444460]
  368. J Med Virol. 2021 Mar;93(3):1532-1537 [PMID: 32860431]
  369. Blood. 2014 Apr 17;123(16):2573-84 [PMID: 24335230]
  370. Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1149-1151 [PMID: 32668401]
  371. Biochem Biophys Res Commun. 2009 Apr 17;381(4):592-6 [PMID: 19245790]
  372. JAMA. 2021 Aug 10;326(6):499-518 [PMID: 34228774]
  373. JCI Insight. 2020 Jul 9;5(13): [PMID: 32501293]
  374. Euro Surveill. 2020 Aug;25(32): [PMID: 32794447]
  375. Am J Respir Crit Care Med. 2011 May 15;183(10):1344-53 [PMID: 21257790]
  376. Lancet Respir Med. 2020 Sep;8(9):853-862 [PMID: 32735842]
  377. Lancet Infect Dis. 2022 Jan;22(1):35-42 [PMID: 34461056]
  378. Lancet Rheumatol. 2020 Jun;2(6):e325-e331 [PMID: 32501454]
  379. Antimicrob Agents Chemother. 2020 Aug 20;64(9): [PMID: 32661006]
  380. Thromb Haemost. 2021 Aug;121(8):1054-1065 [PMID: 33412596]
  381. JAMA. 2021 Jul 20;326(3):230-239 [PMID: 34283183]
  382. Crit Care. 2020 Jul 2;24(1):389 [PMID: 32616077]
  383. Blood. 2020 Jul 23;136(4):489-500 [PMID: 32492712]

MeSH Term

Animals
COVID-19
Humans
SARS-CoV-2
COVID-19 Drug Treatment

Word Cloud

Created with Highcharts 10.0.0COVID-19guidediseaseunderstandingtreatmentNumerousreviewssummarizedepidemiologypathophysiologyvarioustherapeuticaspectsCoronavirus2019practical"howtreatwhen"basedimmunologicalbackgroundstagesremainsmissingreviewattemptscombinecurrentknowledgeimmunopathologypublishedevidenceavailableemergingoptionsrecognizeinformationrapidlychanginghopeoffersfrontlinepandemichostresponsepatientssupportsongoingeffortsselectbesttreatmentstailoredpatient'sclinicalstatushitchhiker'sgalaxy

Similar Articles

Cited By (3)